Gaby is a partner in De Brauw's Corporate practice where she focuses on cross-border equity capital markets and M&amp;A transactions. Gaby's transactional practice includes advising on IPOs, private and public M&amp;A, and joint ventures. In addition to her transactional practice, Gaby advises listed companies on compliance with securities laws and disclosure obligations. Gaby is co-heading the Equity Capital Markets practice. She is also a member of De Brauw's Life Sciences team. She was the resident partner for De Brauw in Shanghai and also worked at De Brauw's New York office. She is actively involved in the firm's international network. Gaby is ranked in Legal 500 for both ECM and M&amp;A, in Chambers for ECM, and in IFLR1000's women leaders in law for the Netherlands.
Gaby's recent Capital Markets work includes advising:
<ul><li>Ferrovial on its re-domiciliation to the Netherlands and listings on Euronext Amsterdam and Nasdaq</li><li>Sodexo on the spin-off of its employee benefits division into Pluxee N.V. and listing on Euronext Paris</li><li>CTP on its EUR 850 million IPO on Euronext Amsterdam</li><li>Philips on the dual track for its Domestic Appliances business</li><li>TechnipFMC on the spin-off and listing of Technip Energies N.V.</li><li>Just Eat Takeaway.com on the merger with Grubhub and on various convertible bond issuances and ABBs</li><li>CM.com on its listing on Euronext Amsterdam through a business combination with a SPAC</li><li>Underwriters on the IPO of LAVA Therapeutics on Nasdaq</li><li>Underwriters on the IPO of CureVac on Nasdaq</li><li>Underwriters on the IPO of Mytheresa on NYSE</li><li>Underwriters on the secondary listing of Marel on Euronext Amsterdam</li><li>AkzoNobel on the dual track for its Specialty Chemicals business</li></ul>
Gaby's recent M&amp;A work includes advising:
<ul><li>Teleperformance on its EUR 3bn public offer on Majorel</li><li>Nolet on its public offer for Lucas Bols</li><li>Heineken on its divestment of Vrumona</li><li>Altice Europe on the recommended public offer by its founder and controlling shareholder</li><li>CM.com on the acquisition of PayPlaza</li><li>BCD on the sale of online travel company Travix to Trip.com</li><li>Beter Bed on the divestment of its DACH business Matratzen Concord</li><li>FrieslandCampina on the acquisition of Nutricima's dairy business in Nigeria</li><li>FrieslandCampina on the sale of its cream liqueur business</li></ul>

Gaby Smeenk 4

Gaby Smeenk

Partner

Féline is counsel in De Brauw’s Corporate practice, with a specific focus on cross-border Equity Capital Markets and Mergers and Acquisitions.
Féline's practice includes advising on private M&amp;A transactions and on all aspects of securities offerings and listings, including prospectus requirements and cross-border clearing and settlement structures. She also assists corporates in their compliance with financial reporting obligations and financial market regulations, including market abuse, ongoing obligations, insider trading issues and stock exchange rules. 
Féline was seconded to a large national bank in 2015/2016 and to the corporate department of the New York law firm, Davis Polk &amp; Wardwell LLP, from September 2022 through August 2023.
Féline's recent work includes advising:
<ul><li>Royal Philips on the dual track for its Domestic Appliances business</li><li>Hapag-Lloyd on its acquisition of NileDutch </li><li>Beter Bed on the divestment of its DACH business, Matratzen Concord </li><li>TechnipFMC on the spin-off and listing of Technip Energies N.V. on Euronext France </li><li>The underwriters on the IPO of LAVA Therapeutics on Nasdaq </li><li>The underwriters on the IPO of Mytheresa B.V. on NYSE </li><li>CM.com on its Euronext listing through a business combination with a SPAC </li><li>Affimed on various capital raises and related securities work </li><li>Unilever and other N.V.'s on US/Europe/Amsterdam cross settlement </li><li>A sophisticated retail business with highly developed omni-channel sales, influencer and return platform on its IPO (aborted in last phase) </li><li>Takeaway.com on its IPO on Euronext Amsterdam </li><li>ABN AMRO on its IPO on Euronext Amsterdam </li><li>Royal Ahold Delhaize on its proposed sub-IPO of bol.com </li><li>Fugro on its rights issue and convertible bond offerings </li><li>EPIC Acquisition Corp, a SPAC, on its EUR 150 million offering and listing on Euronext Amsterdam</li></ul>

Feline goyarts

Féline Goyarts

Counsel

Henk specialises in tax and corporate law and, in particular, mergers and acquisitions and private equity structuring. Since joining De Brauw, Henk has advised numerous multinationals and private equity clients on public and private transactions, leveraged buy-outs, complex cross-border transactions, corporate restructurings, financings and refinancings, and the structuring of management incentive plans.
Legal 500 has recognised Henk as a "leading individual", with Chambers stating that Henk is "up and coming". In 2020, 2021 and 2023, Henk was nominated by MenA.nl (the Dutch M&amp;A awards) as Best M&amp;A Tax Adviser, and he won this award in 2024. 
Henk’s recent work includes advising
<ul><li>Bain Capital on the acquisition of Bugaboo from the founders and the sale of a majority interest to Mubadala capital</li>
 <li>Ardian on the acquisition of Attero from 3i and DWS</li>
 <li>Takeaway.com on numerous M&amp;A transactions including its acquisition of the German business of Delivery Hero and the combinations with both Just Eat and Grubhub</li>
 <li>AkzoNobel on numerous M&amp;A transactions including the separation and sale of its Specialty Chemicals to The Carlyle Group and GIC for EUR 10.1 billion</li>
 <li>Royal Philips on numerous M&amp;A transactions including the EUR 862 million IPO of Philips Lighting (Signify) and the sale of Philips’ 80.1% interest in Lumileds to Apollo</li>
 <li>T-Mobile and Deutsche Telekom on the EUR 5.1 billion sale of T-Mobile Netherlands to Apax and Warburg Pincus, the combination of T-Mobile and Tele2, the divestment of T-Infra and the acquisitions of Vodafone’s fixed line consumer business and Simpel.nl</li>
 <li>Advent and Unit4 on the sale of the Unit4 Dutch software business to Exact Group and various other transactions, including the sale of Unit4 to TA Associates and Partners Group</li>
 <li>Parcom on most of its buy-side and sell-side transactions in the past seven years including the acquisition of Hunkemöller, Wajer Yachts , Zorg van de Zaak, Group of Butchers, Simpel.nl, Yource, MGG Group, ConDoor Group, Koninklijke Euroma, NedacSorboMascot, Outdoor Life Group, and other portfolio companies, and the sale of Altrex, Jan Snel, ConDoor Group, GustoMSC, GoodHabitz, Climate for Life and various other transactions</li>
 <li>Topicus.com on its combination with Total Specific Solutions and subsequent listing on the Toronto Stock Exchange</li>
 <li>Impax Asset Management on the acquisition, financing, development and sale of Zonnepark Vlagtwedde, the largest Dutch solar park (110MW)</li>
 <li>The founder of De Jong Packaging on the sale to Stora Enso</li>
 <li>Fugro on its refinancing transactions and multiple buyside and sell-side acquisitions and divestments</li>
 <li>The Kloosterboer family on the sale of Kloosterboer Group to Lineage (Bay Grove)</li>
 <li>Triton on the acquisition of Royal Reesink from Rivean Capital and a majority stake in Bergman Clinics</li></ul>

Henk vanravenhorst

Henk van Ravenhorst

Noortje engbers extra

Noortje Engbers

Senior Associate

Mees specialises on domestic and cross-border corporate tax law, focusing in particular on advising clients and litigation. He regularly advises businesses on a wide range of tax issues, including reorganisations and tax controversies. Mees is also assistant professor at Leiden University and publishes and lectures on international and European tax law.

Mees vergouwen

Mees Vergouwen

Tax Adviser

Casper represents clients in complex business transactions and advises them on general corporate and governance matters.
Casper has significant experience in assisting companies listed in the Netherlands or elsewhere with the corporate law aspects of domestic or cross-border transactions, spin-offs and securities offerings.
Casper's recent work includes advising: 
<ul><li>Arya Sciences Acquisition Corp. on its joint venture with Immatics Biotechnologies GmbH and its listing on NASDAQ</li>
 <li>TechnipFMC on the separation and Euronext Paris listing of its Technip Energies business</li>
 <li>Qiagen on the USD 12.5 billion offer of Thermo Fisher Scientific</li>
 <li>Pfizer on the USD 22 billion merger of spin-offs Upjohn and Mylan</li>
 <li>RELX on the discontinuation of its dual-headed structure</li>
 <li>CB&amp;I on its USD 6 billion combination with McDermott</li>
 <li>Elastic on its IPO on NYSE </li>
 <li>Signify on its IPO on Euronext Amsterdam</li>
 <li>Avast on its acquisition of NYSE-listed AVG Technologies</li>
 <li>Prosensa on its IPO on Nasdaq and the subsequent USD 840 million offer by Biomarin</li>
 <li>NXP on its acquisition of NASDAQ-listed Freescale Semiconductors</li>
 <li>ABN AMRO Group on its IPO on Euronext Amsterdam and the subsequent simplification of its group structure</li>
 <li>Rabobank on the listing of its depositary receipts on Euronext Amsterdam</li>
</ul>

Casper nagtegaal

Casper Nagtegaal

De Brauw advised the underwriters on the upsized USD 479 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.

Capital 
Markets

Corporate Advisory 
& Corporate Governance

Life Sciences, Pharma
& Healthcare

Home

Matter overview

De Brauw advises underwriters on NewAmsterdam Pharma's USD 479 million public offering of shares and pre-funded warrants

Breadcrumbs

De Brauw is widely recognised as a leading international law firm in the Netherlands. For nearly 150 years, we have been standing by our clients as a strong and spirited collective of leading legal experts. Through profound engagement with the business of our clients and a deep understanding of their ambitions, we build relationships of trust - some of which already stand for more than one hundred years.

De Brauw Blackstone Westbroek

De Brauw advised the underwriters on the upsized USD 479 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.

De Brauw advised the underwriters on the upsized USD 479 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma…

description

generator

law firm,lawyer,legal,legal firm,amsterdam,international law firm

keywords

https://dwbxnuhxoazve.cloudfront.net/Icons/_1200x630_crop_center-center_82_none/og_image.png?mtime=1710424428

https://www.linkedin.com/company/de-brauw-blackstone-westbroek/

https://www.facebook.com/careersatdebrauw

De Brauw advises underwriters on NewAmsterdam Pharma's USD 479…

https://www.debrauw.com/matters/de-brauw-advises-underwriters-on-newamsterdam-pharmas-usd-479-million-public-offering-of-shares-and-pre-funded-warrants

referrer

robots

twitter:card

twitter:creator

twitter:description

https://dwbxnuhxoazve.cloudfront.net/Icons/_800x418_crop_center-center_82_none/og_image.png?mtime=1710424428

Areas of expertise

Sector

Topic

Areas of expertise

Sector

Topic

De Brauw advises underwriters on NewAmsterdam Pharma's USD 479 million public offering of shares and pre-funded warrants

Team

Gaby Smeenk

Féline Goyarts

Henk van Ravenhorst

Noortje Engbers

Locations

Contact

Subscribe